Curcumin-dependent phenotypic transformation of microglia mediates resistance to pseudorabies-induced encephalitis

Luqiu Feng1, Guodong Luo1, Yuhang Li1

  • 1College of Veterinary Medicine, Southwest University, Chongqing, 402460, China.

Veterinary Research
|March 15, 2023
PubMed

Insights

Curcumin (CUR) protects against pseudorabies virus (PRV)-induced encephalitis by shifting microglia from M1 to M2 phenotypes. This improves mitochondrial function and energy metabolism, ultimately protecting neurons from inflammatory damage.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Pseudorabies virus (PRV) causes severe, high-mortality viral encephalitis.
  • Curcumin (CUR) is known to modulate microglial inflammatory responses, but its specific role in PRV encephalitis is not fully understood.
  • Understanding microglial phenotype changes is crucial for developing effective treatments against PRV-induced neurological damage.

Purpose of the Study:

  • To investigate whether curcumin (CUR) can protect against PRV-induced viral encephalitis.
  • To elucidate the mechanisms by which CUR alters microglial phenotypes and impacts neuronal survival.
  • To explore the role of energy metabolism and mitochondrial function in CUR's protective effects against PRV.

Main Methods:

  • BV2 microglial cells were infected with PRV and treated with CUR.
  • Phenotypic polarization (M1/M2), mitochondrial function, and energy metabolism (AMPK, glycolysis, oxidative phosphorylation) were assessed.
  • Neuronal apoptosis induced by M1 microglia secretions was evaluated.
  • In vivo studies assessed CUR's efficacy in mitigating PRV encephalitis symptoms and mortality.

Main Results:

  • CUR promoted PRV-infected BV2 cells to polarize from M1 to M2 phenotype, reversing PRV-induced mitochondrial dysfunction.
  • M1 microglia secretions induced neuronal apoptosis, while M2 secretions abrogated this effect.
  • CUR inhibited PRV-induced increases in AMPK phosphorylation, glycolysis, and triacylglycerol synthesis, while restoring oxidative phosphorylation.
  • CUR treatment reduced PRV-induced mortality, fever, neurological symptoms, and brain pathology in vivo.

Conclusions:

  • Curcumin (CUR) confers protection against PRV-induced viral encephalitis.
  • CUR achieves this by switching microglia from an M1 to an M2 phenotype, improving mitochondrial function and energy metabolism.
  • The protective mechanism involves the AMPK/NF-κB p65-energy metabolism pathway, ultimately safeguarding neurons from inflammatory injury.